Get started
Author

Vanessa Danielson

Observed names: Danielson, Vanessa, V Danielson, V. Danielson
ORCID: 0000-0001-5857-6254
Observed ORCID: 0000-0001-5857-6254
OpenAlex ID: A5011953651
Efficacy and safety of VNS therapy or continued medication management for treatment of adults with drug-resistant epilepsy: systematic review and meta-analysis
2022 · Sarah Batson, Rohit Shankar, et al. · Journal of Neurology · 56
PDF
Real-world evidence of epidemiology, patient characteristics, and mortality in people with drug-resistant epilepsy in the United Kingdom, 2011–2021
2024 · Rohit Shankar, Xiaocong Li Marston, et al. · Journal of Neurology · 34
PDF
An economic evaluation of vagus nerve stimulation as an adjunctive treatment to anti-seizure medications for the treatment of drug-resistant epilepsy in England
2021 · Christopher Raspin, Rohit Shankar, et al. · Journal of Medical Economics · 17
PDF
An economic evaluation of vagus nerve stimulation as an adjunctive treatment to anti-seizure medications for the treatment of drug resistant epilepsy in the United States
2023 · Christopher Raspin, Edward Faught, et al. · Journal of Medical Economics · 15
Comparison of utilization and cost of healthcare services and pharmacotherapy following implantation of vagus nerve stimulation vs. responsive neurostimulation or deep brain stimulation for the treatment of drug-resistant epilepsy: analyses of a large United States healthcare claims database
2022 · Tom Vincent, Qian Li, et al. · Journal of Medical Economics · 15
Patterns of utilization and cost of healthcare services and pharmacotherapy among patients with drug-resistant epilepsy during the two-year period before neurostimulation: A descriptive analysis of the journey to implantation based on analyses of a large United States healthcare claims database
2023 · Kathryn Evans, Nicole Stamas, et al. · Epilepsy & Behavior · 10
PDF
Impact of Vagus Nerve Stimulation for the Treatment of Drug-resistant Epilepsy on Patterns of Use and Cost of Health Care Services and Pharmacotherapy: Comparisons of the 24-Month Periods Before and After Implantation
2023 · Kathryn Evans, Nicole Stamas, et al. · Clinical Therapeutics · 7
Use of Healthcare Claims Data to Generate Real-World Evidence on Patients With Drug-Resistant Epilepsy: Practical Considerations for Research
2024 · Nicole Stamas, Tom Vincent, et al. · Journal of health economics and outcomes research · 5
Impact of Vagus Nerve Stimulation for the Treatment of Drug-resistant Epilepsy on Patterns of Use and Cost of Healthcare Services and Pharmacotherapy Among Medicare Enrollees: Findings From Analyses of Healthcare Claims From the Centers of Medicare and Medicaid Services
2025 · Kathryn Evans, Qian Li, et al. · Clinical Therapeutics · 3
Variation in access to specialist services for neurosurgical procedures in adults with epilepsy in England, a cohort study
2022 · Joanna Murphy, Gillian C Hall, et al. · Seizure · 3
Healthcare Utilization and Cost in the Two Years Before Neuromodulation Implantation Among Medicaid Enrollees with Drug-Resistant Epilepsy
2025 · Kathryn Evans, Qian Li, et al. · ClinicoEconomics and Outcomes Research · 2
PDF
Initiating Patients on Peritoneal Dialysis Compared with In-Centre Haemodialysis in the United Kingdom: A Cost-Utility and Budget Impact Analysis
2026 · Tara Danying Li, Claudia Rinciog, et al. · PharmacoEconomics - Open
PDF
Use of Tokenization to Overcome Coding Challenges in Real-World Data: Identification and Assessment of Remote Patient Monitoring (RPM) in Peritoneal Dialysis (PD)
2026 · Kathryn Evans, Rhonda Shaw, et al. · Journal of the American Society of Nephrology
Real-World Analysis of the Association Between Kidney Disease Education (KDE) and Peritoneal Dialysis (PD)
2026 · Firas Dabbous, Julie Brown, et al. · Journal of the American Society of Nephrology
Effect of Remote Patient Monitoring (RPM) for Peritoneal Dialysis (PD) on Health Care Resource Use (HCRU) Among US Patients with ESKD
2026 · Kathryn Evans, Rhonda Shaw, et al. · Journal of the American Society of Nephrology
Estimating the Cost-Effectiveness of Peritoneal Dialysis Compared with Hemodialysis as a Starting Modality in the United States
2026 · Araadhna Sinha, Eric Adam Simonic, et al. · Journal of the American Society of Nephrology
Estimating the Budget Impact of Peritoneal Dialysis Compared with Hemodialysis in the United States
2026 · Araadhna Sinha, Eric Adam Simonic, et al. · Journal of the American Society of Nephrology
HSD89 The Patient Journey Prior to Neuromodulation in Drug-Resistant Epilepsy, Patterns of Utilization and Cost of Healthcare Services and Pharmacotherapy Based on a Claim Database in the United States
2023 · R. Lassagne, L. Zhang, et al. · Value in Health
PDF
EE75 Cost-Effectiveness of Heart Failure Treatments– A Targeted Literature Review
2022 · R Cai, N Mishra, et al. · Value in Health
POSC289 Cost-Effectiveness of Vagus Nerve Stimulation with Anti-Seizure Medication Versus Anti-Seizure Medication Alone in the Management of Drug Resistant Epilepsy in England
2022 · C. Raspin, R. Shankar, et al. · Value in Health
Works count: 22
Citation count: 167
H-index: 7
I10-index: 6
Year
Topic
Type